Price $8.75 |
Market Cap
234.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
24.8
|
P/B
20.1
|
P/S
6.87
|
Dividend %
-
|
|
P/CF
49.0
|
P/FCF
35.6
|
Op. Cash Flow
10.2K
|
FCF
0.2
|
|
Op. Margin
31.10%
|
Net Margin
29.20%
|
ROE
105.20%
|
ROI
103.30%
|
|
ROA
63.60%
|
EPS Growth
12.10%
|
Current Ratio
2.0
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| R1 RCM Inc (RCM) | $11.60 | - | - | 1.32B | Strong Buy |
| TearLab Corp (TEAR) | $0.09 | - | - | 1.1M | Strong Buy |
| Fulgent Genetics Inc (FLGT) | $6.09 | - | - | 106.5M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $21.47 | - | - | 7.55B | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.38 | - | - | 56.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
